Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Utilizing pluripotent stem cells in cell therapy

Utilizing pluripotent stem cells in cell therapy

FromConversations in Healthcare


Utilizing pluripotent stem cells in cell therapy

FromConversations in Healthcare

ratings:
Length:
26 minutes
Released:
Dec 2, 2020
Format:
Podcast episode

Description

In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Brian Culley, CEO of Lineage Cell Therapeutics. Brian and Mike discuss the company’s cell therapy program, utilizing pluripotent stem cells, initially targeting dry age-related macular degeneration, acute spinal cord injuries, and non-small cell lung cancer. Brian shares about the status of their Phase 1/2a clinical trials, and how COVID-19 has affected the company’s operations. Hosted on Acast. See acast.com/privacy for more information.
Released:
Dec 2, 2020
Format:
Podcast episode

Titles in the series (48)

Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the industry currently faces, including COVID-19, clinical innovation, deal making, emerging market dynamics, data and technology, new engagement models, patient centricity and much more.   Hosted on Acast. See acast.com/privacy for more information.